about
Epigenetic modulators, modifiers and mediators in cancer aetiology and progressionNext-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?Keep-ING balance: tumor suppression by epigenetic regulationDisruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathThe Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear StructureSpecifying peripheral heterochromatin during nuclear lamina reassembly.Glycolytic metabolism influences global chromatin structureEarly Prediction of Cancer Progression by Depth-Resolved Nanoscale Mapping of Nuclear Architecture from Unstained Tissue Specimens.The epigenetic basis of common human disease.DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11.Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization.Chrom3D: three-dimensional genome modeling from Hi-C and nuclear lamin-genome contacts.Harnessing the potential of epigenetic therapy to target solid tumors.Sizing and shaping the nucleus: mechanisms and significance.Epigenetic Determinants of Cancer.Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape.Causes and consequences of nuclear envelope alterations in tumour progression.Mechanobiology of Chromatin and the Nuclear Interior.Spatial localization of genes determined by intranuclear DNA fragmentation with the fusion proteins lamin KRED and histone KRED und visible light.SET oncoprotein accumulation regulates transcription through DNA demethylation and histone hypoacetylation.The visualization of large organized chromatin domains enriched in the H3K9me2 mark within a single chromosome in a single cell.Chromatin histone modifications and rigidity affect nuclear morphology independent of lamins.Distinct Trends of DNA Methylation Patterning in the Innate and Adaptive Immune Systems.Fourier phase based depth-resolved nanoscale nuclear architecture mapping for cancer detection.Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.
P2860
Q26766149-3CA498CA-AC8D-44DC-950A-8EA4251FAB63Q26781271-E57E2B09-DC15-4194-812B-9ACB329B7019Q26859017-F6CD0F98-4DD8-40CD-AFD2-D09EE76A2BA2Q28080874-986D6EBA-089F-40E6-BF95-DE134266FC51Q28084785-742D5177-525D-47CC-8319-3DDD6A29A6B0Q33638741-8737624E-37FE-4892-A65B-11B4752E9472Q35580164-FF4CDA22-A95F-4511-B16B-68A82AB0A1B1Q36296548-84026B46-AB23-41E0-9722-00FA48C0B4C6Q37026078-C233B28B-6659-4AF5-A83F-A3B933F4C6A2Q37445288-4EAEF5EE-1750-4E31-968C-4F80329717C5Q37550182-688CE1BB-0601-4325-8BF8-9BFCF935B0D0Q37612740-958F4E83-B9E9-4854-89B2-DE8F3B771B3AQ38175087-E44DAD6B-1ABF-4D6E-BC4B-2EDABD6AB078Q38185842-1D395C1F-7DE9-411C-8FAD-7436364CB490Q38837858-A333619D-3D7B-47FC-8D31-160B020E1D1FQ38843250-9E36CA5A-D001-401F-BF16-7CDFACA733D3Q38891711-2C06CAE8-5119-4BFB-B269-2DBC19B78ABAQ39121085-CAEDFBC7-97F6-4C02-A3AD-4CBBAAA32903Q39123568-000BF867-A660-4006-9728-3619CF9B1487Q41809641-B069D56F-69FA-4609-915E-15C688CFF9AEQ43199126-EF49117D-5493-44DA-8CB4-16C808F5166CQ47344586-1884D110-E15A-4115-8255-20D2A4AF5D7EQ47372352-5D3D0A8C-F29A-44AD-84E4-57B2D1C7285CQ50064077-2CD955F6-CC1E-49B6-B830-612DFA6091B5Q53048458-CFE77420-C748-489C-AFB6-DFCCEB9748E6
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Higher order chromatin organization in cancer
@ast
Higher order chromatin organization in cancer
@en
Higher order chromatin organization in cancer
@nl
type
label
Higher order chromatin organization in cancer
@ast
Higher order chromatin organization in cancer
@en
Higher order chromatin organization in cancer
@nl
prefLabel
Higher order chromatin organization in cancer
@ast
Higher order chromatin organization in cancer
@en
Higher order chromatin organization in cancer
@nl
P2860
P1476
Higher order chromatin organization in cancer
@en
P2093
Andrew P. Feinberg
Karen L. Reddy
P2860
P304
P356
10.1016/J.SEMCANCER.2012.12.001
P407
P577
2013-04-01T00:00:00Z